Pure Global

IVD Department, Total T3 Quantitative Testing - Vietnam Registration 240000053/PCBB-BYT

Access comprehensive regulatory information for IVD Department, Total T3 Quantitative Testing in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại B medical device is registered under number 240000053/PCBB-BYT and manufactured by Ortho-Clinical Diagnostics. The authorized representative in Vietnam is CÔNG TY CỔ PHẦN THIẾT BỊ SISC VIỆT NAM.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
240000053/PCBB-BYT
Registration Details
Vietnam MOH Registration: 240000053/PCBB-BYT
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

IVD Department, Total T3 Quantitative Testing
VN: Bộ IVD xét nghiệm định lượng T3 tổng số
Risk Class TTBYT Loại B

Registration Details

240000053/PCBB-BYT

000.00.04.G18-240326-0005

Theo theo phụ lục

Theo phụ lục

Company Information

Theo theo phụ lục

Ortho-Clinical Diagnostics

Technical Details

The IVD Quantitative Total T3 Assay Kit consists of the following components: (1) VITROS Immunodiagnostic Products Total T3 Reagent Pack: For in vitro diagnostic quantitative determination of total triiodothyronine (T3) in human serum and plasma (EDTA or heparin) on the VITROS ECi/ECiQ/3600 and VITROS 5600/XT 7600 Immunoassay Systems, to aid in the differential diagnosis of thyroid disorders. (2) VITROS Immunodiagnostic Products Total T3 Calibrators: For in vitro diagnostic calibration of the VITROS ECi/ECiQ/3600 and VITROS 5600/XT 7600 Immunoassay Systems when quantitating total triiodothyronine (T3) in human serum and plasma (EDTA or heparin).

Dates and Status

Apr 04, 2024